Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice

Vaccine

Volumn 26, Issue 20, 2008, Pages 2457-2465

  Phumoonna, Tongted ^a,b   Barton, Mary D ^b   Vanniasinkam, Thiru ^c   Heuzenroeder, Michael W ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c CHARLES STURT UNIVERSITY   (Australia)

Author keywords

DNA vaccines; groEL2 and vapA; Rhodococcus equi

Indexed keywords

DNA VACCINE; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; PCDNA3 RE1; PCDNA3 RE3; PCDNA3 RE5; VAPA GROEL2 PROTEIN; VIRULENCE ASSOCIATED PROTEIN A;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL PNEUMONIA; C3H MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA VECTOR; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHODOCOCCUS EQUI; TH1 CELL;

ACTINOMYCETALES INFECTIONS; AEROSOLS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; COLONY COUNT, MICROBIAL; FEMALE; GROEL PROTEIN; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED C3H; RHODOCOCCUS EQUI; SPLEEN; VACCINES, DNA; VIRULENCE FACTORS;

EID: 42649084667     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.015     Document Type: Article

References (41)

1. Hondalus M.K., and Mosser D.M. Survival and replication of Rhodococcus equi in macrophages. Infect Immun 62 10 (1994) 4167-4175
2. Prescott J.F. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev 4 1 (1991) 20-34
3. Weinstock D.M., and Brown A.E. Rhodococcus equi: an emerging pathogen. Clin Infect Dis 34 10 (2002) 1379-1385
4. Varga J., Fodor L., Rusvai M., Soos I., and Makrai L. Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines. Vet Microbiol 56 3/4 (1997) 205-212
5. Prescott J.F., Nicholson V.M., Patterson M.C., Zandona Meleiro M.C., Caterino de Araujo A., Yager J.A., et al. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R. equi pneumonia. Am J Vet Res 58 4 (1997) 356-359
6. Fernandez A.S., Prescott J.F., and Nicholson V.M. Protective effect against Rhodococcus equi infection in mice of IgG purified from horses vaccinated with virulence associated protein (VapA)-enriched antigens. Vet Microbiol 56 3/4 (1997) 187-192
7. Becu T., Polledo G., and Gaskin J.M. Immunoprophylaxis of Rhodococcus equi pneumonia in foals. Vet Microbiol 56 3/4 (1997) 193-204
8. Chaffin M.K., Cohen N.D., and Martens R.J. Evaluation of equine breeding farm characteristics as risk factors for development of Rhodococcus equi pneumonia in foals. J Am Vet Med Assoc 222 4 (2003) 467-475
9. Higuchi T., Arakawa T., Hashikura S., Inui T., Senba H., and Takai S. Effect of prophylactic administration of hyperimmune plasma to prevent Rhodococcus equi infection on foals from endemically affected farms. Zentralbl Veterinarmed [B] 46 9 (1999) 641-648
10. Hurley J.R., and Begg A.P. Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals. Aust Vet J 72 11 (1995) 418-420
11. Perkins G.A., Yeager A., Erb H.N., Nydam D.V., Divers T.J., and Bowman J.L. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma. Vet Ther 3 3 (2002) 334-346
12. Jain S., Bloom B.R., and Hondalus M.K. Deletion of vapA encoding virulence associated protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol Microbiol 50 1 (2003) 115-128
13. Giguere S., Hondalus M.K., Yager J.A., Darrah P., Mosser D.M., and Prescott J.F. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun 67 7 (1999) 3548-3557
14. Takai S., Sekizaki T., Ozawa T., Sugawara T., Watanabe Y., and Tsubaki S. Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi. Infect Immun 59 11 (1991) 4056-4060
15. Lopez A.M., Hines M.T., Palmer G.H., Knowles D.P., Alperin D.C., and Hines S.A. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi. Vaccine 21 25/26 (2003) 3815-3825
16. Cauchard J., Sevin C., Ballet J.J., and Taouji S. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine. Vet Microbiol 104 December 30 (1/2) (2004) 73-81
17. Vanniasinkam T., Barton M.D., and Heuzenroeder M.W. Immune response to vaccines based upon the VapA protein of the horse pathogen, Rhodococcus equi, in a murine model. Int J Med Microbiol 294 January (7) (2005) 437-445
18. Haghighi H.R., and Prescott J.F. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection. Vet Immunol Immunopathol 104 April 8 (3/4) (2005) 215-225
19. Zeilstra-Ryalls J., Fayet O., and Georgopoulos C. The universally conserved GroE (Hsp60) chaperonins. Annu Rev Microbiol 45 (1991) 301-325
20. de Leon P., Marco S., Isiegas C., Marina A., Carrascosa J.L., and Mellado R.P. Streptomyces lividans groES, groEL1 and groEL2 genes. Microbiology 143 November (Pt 11) (1997) 3563-3571
21. Lathigra R.B., Butcher P.D., Garbe T.R., and Young D.B. Heat shock proteins as virulence factors of pathogens. Curr Top Microbiol Immunol 167 (1991) 125-143
22. Phumoonna T., Barton M.D., and Heuzenroeder M.W. Recognition of a B-cell epitope of the VapA protein of Rhodococcus equi in newborn and experimentally infected foals. J Vet Med B: Infect Dis Vet Public Health 52 August (6) (2005) 291-295
23. Taouji S., Breard E., Peyret-Lacombe A., Pronost S., Fortier G., and Collobert-Laugier C. Serum and mucosal antibodies of infected foals recognized two distinct epitopes of VapA of Rhodococcus equi. FEMS Immunol Med Microbiol 34 4 (2002) 299-306
24. Vanniasinkam T., Barton M.D., and Heuzenroeder M.W. B-cell epitope mapping of the VapA protein of Rhodococcus equi: implications for early detection of R. equi disease in foals. J Clin Microbiol 39 4 (2001) 1633-1637
25. Vanniasinkam T., Barton M.D., and Heuzenroeder M.W. The immunogenicity of Rhodococcus equi GroEL2-based vaccines in a murine model. Vet Immunol Immunopathol 98 1/2 (2004) 91-100
26. Barton M.D., and Hughes K.L. Comparison of three techniques for isolation of Rhodococcus (Corynebacterium) equi from contaminated sources. J Clin Microbiol 13 1 (1981) 219-221
27. Barton M.D., and Embury D.H. Studies of the pathogenesis of Rhodococcus equi infection in foals. Aust Vet J 64 11 (1987) 332-339
28. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA p. 1.25-1.39
29. Liu S., Tobias R., McClure S., Styba G., Shi Q., and Jackowski G. Removal of endotoxin from recombinant protein preparations. Clin Biochem 30 August (6) (1997) 455-463
30. Gonzalez-Juarrero M., Turner J., Basaraba R.J., Belisle J.T., and Orme I.M. Florid pulmonary inflammatory responses in mice vaccinated with Antigen-85 pulsed dendritic cells and challenged by aerosol with Mycobacterium tuberculosis. Cell Immunol 220 November (1) (2002) 13-19
31. Jiang C., Magee D.M., and Cox R.A. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis. Infect Immun 67 November (11) (1999) 5848-5853
32. Dewhirst F.E., Chien C.C., Paster B.J., Ericson R.L., Orcutt R.P., Schauer D.B., et al. Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 65 August (8) (1999) 3287-3292
33. Arulanandam B.P., and Metzger D.W. Modulation of mucosal and systemic immunity by intranasal interleukin 12 delivery. Vaccine 17 January 21 (3) (1999) 252-260
34. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17 March (3) (1996) 138-146
35. Kanaly S.T., Hines S.A., and Palmer G.H. Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect Immun 64 4 (1996) 1126-1132
36. Hines S.A., Kanaly S.T., Byrne B.A., and Palmer G.H. Immunity to Rhodococcus equi. Vet Microbiol 56 3/4 (1997) 177-185
37. Patton K.M., McGuire T.C., Hines M.T., Mealey R.H., and Hines S.A. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect Immun 73 April (4) (2005) 2083-2093
38. Hines S.A., and Hietala S.K. Rhodococcal pneumonia: humoral versus cell-mediated immunity. Equine Vet J 28 5 (1996) 339-340
39. Winslow G.M., Yager E., Shilo K., Volk E., Reilly A., and Chu F.K. Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection. Infect Immun 68 April (4) (2000) 2187-2195
40. Nordmann P., Ronco E., and Nauciel C. Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun 60 7 (1992) 2748-2752
41. Kanaly S.T., Hines S.A., and Palmer G.H. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infect Immun 63 8 (1995) 3037-3041